Trial intelligence / Profile preview

Niacinamide for prevention of postoperative delirium in elderly non-cardiac surgery patients

ChiCTR2400087479Phase 4Not yet recruiting

Sponsor
The Second Affiliated Hospital of Nanjing Medical University
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postoperative delirium (POD) comparing intraoperative niacinamide with Control: intraoperative placebo (2 arms). Primary endpoint: Incidence of postoperative delirium. Planned start Jul 2024; status: not yet recruiting.

02

Drugs

nicotinamide
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR2400087479.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400087479.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call